Majority of Patients Treated with Lebrikizumab Achieved Skin Clearance in Lilly's Pivotal Phase 3 Atopic Dermatitis Studies
Posted:
Millions of people with atopic dermatitis cope with both seen and unseen burdens of the disease. Discover more about important new clinical trial results and how Lilly is helping to improve care and understanding of this disease here.
Join Thames Freeport expert panelists on April 14th 11:30am-12:30pm, for a powerful discussion about the potential of AI in the UK’s Health & Social care system.
Read more details here.
The demand for artificial intelligence courses in UK universities has surged dramatically over the past five years, with enrollments increasing by 453%, according to a recent study by Currys, a UK tech retailer.
The study, which analyzed UK university admissions…
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us